Samik Upadhaya, PhD, research analyst, is speaking on the “Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies” virtual panel session on February 25 at 2:45 PM ET.
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 7th Annual Immuno-Oncology 360° Delivers Three Key Benefits:
Access to KOLs driving the science
Partnership opportunities with all stakeholders in Immuno-Oncology
Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology
2021 Key Topic Areas
- Discovery/Preclinical Science
- Cell & Gene Therapy
- Translational Science
- Bispecifics
- Clinical Developments
- Neoadjuvant/Adjuvant Data
- Emerging Biomarkers
- Vaccines
- Clinical Operations
- AI & Machine Learning
- Imaging Advancements
- Business Developments
